Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gareth Hardy

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of HIV Therapy|July 4, 2003
Timing of antiretroviral therapy: an immunological perspectiveNesrina Imami, Gareth Hardy
Current Opinion in Infectious Diseases|April 20, 2002
The immune system: our best antiretroviralFrances Gotch, Gareth Hardy
Emergency Medicine Journal : EMJ|May 21, 2016
BET 2: Should real resuscitationists use airway checklists?Gareth Hardy, Daniel Horner
Journal of Acquired Immune Deficiency Syndromes (1999)|June 24, 2004
Initiation of antiretroviral therapy during recent HIV-1 infection results in lower residual viral reservoirsAntonio Pires, Gareth Hardy, Brian Gazzard, et al.
AIDS (London, England)|January 27, 2007
Specificity of anti-human leukocyte antigen antibody responses after immunization with Remune, an inactivated HIV-1 vaccineMark Page, Agatha Ojugo, Nesrina Imami, et al.
Journal of Virology|August 21, 2002
A balanced type 1/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infectionNesrina Imami, Antonio Pires, Gareth Hardy, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|September 5, 2002
Immune reconstitution in HIV-1-infected patientsNesrina Imami, Gareth Hardy, Antonio Pires, et al.
AIDS Research and Human Retroviruses|March 18, 2003
Thymic output during initial highly active antiretroviral therapy (HAART) and during HAART supplementation with interleukin 2 and/or with HIV type 1 immunogen (Remune)Jeffrey Pido-Lopez, Catherine Burton, Gareth Hardy, et al.
The Journal of Infectious Diseases|January 6, 2007
Reconstitution of herpes simplex virus-specific T cell immunity in HIV-infected patients receiving highly active antiretroviral therapyMeghna Ramaswamy, Anele Waters, Colette Smith, et al.
Immunology|April 23, 2013
Circulating CD4(+) and CD8(+) T cells are activated in inflammatory bowel disease and are associated with plasma markers of inflammationNicholas T Funderburg, Samantha R Stubblefield Park, Hannah C Sung, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of HIV Therapy|July 4, 2003
Timing of antiretroviral therapy: an immunological perspectiveNesrina Imami, Gareth Hardy
Current Opinion in Infectious Diseases|April 20, 2002
The immune system: our best antiretroviralFrances Gotch, Gareth Hardy
Emergency Medicine Journal : EMJ|May 21, 2016
BET 2: Should real resuscitationists use airway checklists?Gareth Hardy, Daniel Horner
Journal of Acquired Immune Deficiency Syndromes (1999)|June 24, 2004
Initiation of antiretroviral therapy during recent HIV-1 infection results in lower residual viral reservoirsAntonio Pires, Gareth Hardy, Brian Gazzard, et al.
AIDS (London, England)|January 27, 2007
Specificity of anti-human leukocyte antigen antibody responses after immunization with Remune, an inactivated HIV-1 vaccineMark Page, Agatha Ojugo, Nesrina Imami, et al.
Journal of Virology|August 21, 2002
A balanced type 1/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infectionNesrina Imami, Antonio Pires, Gareth Hardy, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|September 5, 2002
Immune reconstitution in HIV-1-infected patientsNesrina Imami, Gareth Hardy, Antonio Pires, et al.
AIDS Research and Human Retroviruses|March 18, 2003
Thymic output during initial highly active antiretroviral therapy (HAART) and during HAART supplementation with interleukin 2 and/or with HIV type 1 immunogen (Remune)Jeffrey Pido-Lopez, Catherine Burton, Gareth Hardy, et al.
The Journal of Infectious Diseases|January 6, 2007
Reconstitution of herpes simplex virus-specific T cell immunity in HIV-infected patients receiving highly active antiretroviral therapyMeghna Ramaswamy, Anele Waters, Colette Smith, et al.
Immunology|April 23, 2013
Circulating CD4(+) and CD8(+) T cells are activated in inflammatory bowel disease and are associated with plasma markers of inflammationNicholas T Funderburg, Samantha R Stubblefield Park, Hannah C Sung, et al.
Pageof 2